A landmark study published in the journal Nature has fundamentally altered the scientific understanding of chronic myeloid leukemia (CML), revealing…
Read More
Ludwig Cancer Research Study Reveals Novel Combination Therapy for Acute Myelogenous Leukemia Targeting Epigenetic Barriers to Cell Differentiation
A collaborative international study led by researchers at Ludwig Cancer Research has identified a breakthrough therapeutic strategy for acute myelogenous…
Read More
Merck & Co. Acquires Terns Pharmaceuticals, Bolstering Chronic Myeloid Leukemia Pipeline with FDA Breakthrough Designation for TERN-701
Merck & Co. (MSD) has successfully completed its acquisition of Terns Pharmaceuticals, a strategic move that significantly enhances MSD’s portfolio…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
A recent population-based study, published in CANCER, a prestigious journal of the American Cancer Society, has brought to light a…
Read More
Unveiling the Hidden Acceleration: Study Reveals Explosive Growth and Evolutionary Timeline of Chronic Myeloid Leukemia Years Before Diagnosis
In a groundbreaking study published in the journal Nature on April 9, researchers from the Wellcome Sanger Institute and their…
Read More
Ludwig Cancer Research Study Reveals Novel Combination Therapy for Acute Myelogenous Leukemia Targeting LSD1 and GSK3 Enzymes
In a significant advancement for hematological oncology, researchers from Ludwig Cancer Research have identified a promising new therapeutic strategy to…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
The landscape of cancer care is undergoing a profound transformation, marked by significant advancements in diagnostics and therapeutics that have…
Read More
Rapid Growth and Early Origins of Chronic Myeloid Leukemia Revealed Through Whole Genome Sequencing Analysis
Researchers from the Wellcome Sanger Institute and their international collaborators have uncovered the precise evolutionary timeline of chronic myeloid leukemia…
Read More
Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Treatment through Epigenetic Reprogramming
Acute myelogenous leukemia (AML) remains one of the most formidable challenges in modern oncology, characterized by a rapid progression and…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
The landscape of cancer care is undergoing a profound transformation, marked by significant advancements in treatment modalities that have dramatically…
Read More
